Additionally, Bayorh et al. (2003) found that losartan mitigated oxidative stress-induced HTN and that the effect was partly mediated by angiotensin II (Ang II) and prostanoid endothelium-derived factors. This evidence concerns the gene AGT and hypertensive disorder.